TNFSF10 and breast cancer: Treatment of breast cancer cells with a vehicle control, ONC201 alone, or recombinant human TRAIL (rhTRAIL) alone does not induce PARP or caspase cleavage (Figure 3A, Supplementary Figure 4A).